Semaglutide Study Initiated to Investigate Visceral Adipose Tissue and Liver Changes in CKD Patients
Visceral Adipose Tissue and Liver Changes Associated With Semaglutide in CKD
Abstract
A new study is recruiting patients to investigate how Semaglutide affects visceral adipose tissue and liver function in chronic kidney disease.
TitrateLab articles covering Semaglutide
Written by TitrateLab, separately from the study summarized above.
